ESC 2023: Semaglutide Benefits Patients With Heart Failure With Preserved Ejection Fraction and Obesity
Benefits include significant reductions in symptoms and physical limitations with improvements in exercise function and weight loss versus placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.